-transparent.png){kind=logo}
RAS mutations are found in about 25% of acute myeloid leukemia (AML) cases. The importance of these changes is unknown. If RAS mutations confer growth advantage to leukemia subclones in which they emerge, substantially more nonconservative than conservative mutations should be found. The incidence of conservative mutations was not reported previously. We sequenced N-RAS and K-RAS codons 12 and 13 and N-RAS codon 61 in 20 subjects with newly diagnosed AML. Four nonconservative N-RAS mutations and 4 conservative K-RAS mutations were found. There were no differences between subjects with AML and nonconservative RAS mutations and those with conservative or without RAS mutations. Additional studies are needed to examine the incidence of conservative RAS mutations in subjects with AML.
I Aurer, and
B Labar, and
D Nemet, and
R Ajduković, and
V Bogdanić, and
R P Gale
September 2013,
Leukemia,
I Aurer, and
B Labar, and
D Nemet, and
R Ajduković, and
V Bogdanić, and
R P Gale
April 1987,
Blood,
I Aurer, and
B Labar, and
D Nemet, and
R Ajduković, and
V Bogdanić, and
R P Gale
June 1993,
American journal of hematology,
I Aurer, and
B Labar, and
D Nemet, and
R Ajduković, and
V Bogdanić, and
R P Gale
June 2014,
Annals of hematology,
I Aurer, and
B Labar, and
D Nemet, and
R Ajduković, and
V Bogdanić, and
R P Gale
April 1998,
Chinese medical journal,
I Aurer, and
B Labar, and
D Nemet, and
R Ajduković, and
V Bogdanić, and
R P Gale
May 2012,
Leukemia & lymphoma,
I Aurer, and
B Labar, and
D Nemet, and
R Ajduković, and
V Bogdanić, and
R P Gale
October 2022,
Zhongguo shi yan xue ye xue za zhi,
I Aurer, and
B Labar, and
D Nemet, and
R Ajduković, and
V Bogdanić, and
R P Gale
June 2001,
Blood,
I Aurer, and
B Labar, and
D Nemet, and
R Ajduković, and
V Bogdanić, and
R P Gale
October 1994,
Leukemia,
I Aurer, and
B Labar, and
D Nemet, and
R Ajduković, and
V Bogdanić, and
R P Gale
November 2004,
Haematologica,
